Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
Overview | Financials
Company Name | Arcturus Therapeutics Holdings Inc. |
Symbol | ARCT |
Currency | USD |
Price | 15.48 |
Market Cap | 419,312,952 |
Dividend Yield | 0% |
52-week-range | 14.3 - 45 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joseph E. Payne M.Sc. |
Website | https://arcturusrx.com |
An error occurred while fetching data.
About Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD